title: Effects of necrotic enteritis challenge on intestinal micro-architecture and mucin profile.
abstract: 1. This study investigated the effect of Eimeria spp./Clostridium perfringens induced necrotic enteritis and traditional antibiotic preventatives on intestinal micro-architecture and mucin profile. 2. A total of 600 Cobb 500 broiler chickens were randomly assigned to the following three groups: (i) unchallenged, (ii) challenged, and (iii) zinc bacitracin/monensin (ZnB/monensin) (n = 25 chickens/pen, 8 pens/group). The challenged and ZnB/monensin chickens were individually inoculated with Eimeria acervulina, E. maxima and E. tenella and C. perfringens type A (EHE-NE18) at 9 and 15 d post-hatch respectively, to induce necrotic enteritis. 3. The challenge procedure significantly decreased villus height, increased villus width and increased crypt depth in the challenged compared to the unchallenged chickens. Zinc bacitracin and monensin maintained villus-crypt structure similar to that of the unchallenged chickens. 4. Mucin profile was not affected by Eimeria spp./C. perfringens challenge as demonstrated by periodic acid-Schiff and high iron diamine-alcian blue pH 2 x 5 staining. Zinc bacitracin and monensin decreased the number of intestinal mucin-containing goblet cells. 5. Lectin histochemistry showed a trend towards greater Arachis hypogea (PNA) reactivity in unchallenged chickens. 6. In summary, Eimeria spp./C. perfringens challenge disrupted intestinal micro-architecture; however, challenge did not appear to affect intestinal mucin profile. Traditional antibiotics, zinc bacitracin and monensin maintained micro-architecture.
authors.affiliation: School of Animal and Veterinary Sciences, The University of Adelaide, Roseworthy Campus, South Australia, Australia, 5371. hgol2143@uni.sydney.edu.au
authors.forename: H M
authors.initials: HM
authors.lastname: Golder
authors.forename: M S
authors.initials: MS
authors.lastname: Geier
authors.forename: R E A
authors.initials: RE
authors.lastname: Forder
authors.forename: P I
authors.initials: PI
authors.lastname: Hynd
authors.forename: R J
authors.initials: RJ
authors.lastname: Hughes
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001414:Bacitracin / Q000494:pharmacology; D002645:Chickens; D003015:Clostridium Infections / Q000188:drug therapy / Q000382:microbiology / Q000662:veterinary; D003016:Clostridium perfringens / Q000254:growth & development; D003048:Coccidiosis / Q000188:drug therapy / Q000469:parasitology / Q000662:veterinary; D003049:Coccidiostats / Q000494:pharmacology; D004539:Eimeria / Q000254:growth & development; D004751:Enteritis / Q000188:drug therapy / Q000382:microbiology / Q000469:parasitology / Q000662:veterinary*; D020397:Goblet Cells / Q000276:immunology / Q000473:pathology; D007410:Intestinal Diseases / Q000188:drug therapy / Q000382:microbiology / Q000469:parasitology / Q000662:veterinary*; D007422:Intestines / Q000382:microbiology / Q000469:parasitology / Q000473:pathology*; D037102:Lectins / Q000276:immunology; D008985:Monensin / Q000494:pharmacology; D009077:Mucins / Q000378:metabolism*; D009336:Necrosis / Q000188:drug therapy / Q000382:microbiology / Q000469:parasitology / Q000662:veterinary; D011201:Poultry Diseases / Q000188:drug therapy / Q000382:microbiology* / Q000469:parasitology*; D011897:Random Allocation; D013021:South Australia; D013045:Species Specificity
chemical_list: D000900:Anti-Bacterial Agents; D003049:Coccidiostats; D037102:Lectins; D009077:Mucins; D001414:Bacitracin; D008985:Monensin